跳转至内容
Merck
CN

SML1394

奥美沙坦

≥98% (HPLC), Angiotensin II Type I receptor blocker, powder

别名:

4-(1-羟基-1-甲基乙基)-2-丙基-1- [ [2′--(2H-四唑-5-基) [1,1′--联苯 ]-4-基 ] 甲基 ]-1H-咪唑-5-羧酸, 奥美沙坦酸

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C24H26N6O3
化学文摘社编号:
分子量:
446.50
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

奥美沙坦, ≥98% (HPLC)

Quality Level

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 20 mg/mL, clear

storage temp.

2-8°C

SMILES string

OC(C)(C)C1=C(C(O)=O)N(CC2=CC=C(C3=C(C4=NNN=N4)C=CC=C3)C=C2)C(CCC)=N1

InChI

1S/C24H26N6O3/c1-4-7-19-25-21(24(2,3)33)20(23(31)32)30(19)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)22-26-28-29-27-22/h5-6,8-13,33H,4,7,14H2,1-3H3,(H,31,32)(H,26,27,28,29)

InChI key

VTRAEEWXHOVJFV-UHFFFAOYSA-N

Gene Information

human ... AGTR1(185)

Application

奥美沙坦已用作血管紧张素 II 受体 1(AT1) 的受体抑制剂,用于研究血管紧张素 II 1 型受体相互作用在调节血管紧张素 II 依赖性高血压中肾传入小动脉的作用。

Biochem/physiol Actions

奥美沙坦具有抗炎和抗氧化应激特性。它保护神经元细胞免于低聚淀粉样蛋白β(Aβ)诱导的细胞衰老。
奥美沙坦是一种血管紧张素 ⅡⅠ 型受体阻滞剂。
奥美沙坦是一种血管紧张素 ⅡⅠ 型受体阻滞剂。奥美沙坦是降压药奥美沙坦酯的活性形式。

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Ariadne M Brondi et al.
Journal of analytical methods in chemistry, 2017, 4878316-4878316 (2018-02-03)
A study was carried out to investigate compatibility of amlodipine besylate and olmesartan medoxomil with a variety of pharmaceutical excipients. Both drugs are antihypertensive agents that can be administered alone, in monotherapy, or in pharmaceutical association. The studies were performed
Ferrán Catalá-López et al.
PLoS medicine, 13(3), e1001971-e1001971 (2016-03-10)
Medications aimed at inhibiting the renin-angiotensin system (RAS) have been used extensively for preventing cardiovascular and renal complications in patients with diabetes, but data that compare their clinical effectiveness are limited. We aimed to compare the effects of classes of
C Custodero et al.
Ageing research reviews, 46, 42-59 (2018-05-29)
Growing evidence suggests chronic low-grade inflammation (LGI) as a possible mechanism underlying the aging process. Some biological and pharmaceutical compounds may reduce systemic inflammation and potentially avert functional decline occurring with aging. The aim of the present meta-analysis was to
Nanako Muraya et al.
Oxidative medicine and cellular longevity, 2018, 7635274-7635274 (2018-07-04)
Oxidative stress induced by hyperuricemia is closely associated with the renin-angiotensin system, as well as the onset and progression of cardiovascular disease (CVD) and chronic kidney disease (CKD). It is therefore important to reduce oxidative stress to treat hyperuricemia. We
Elham Bakhtiari et al.
Toxicology mechanisms and methods, 25(8), 614-621 (2015-09-04)
Over expression of renin-angiotensin system (RAS) and nuclear factor-kappaB (NF-κB) has a major role in many cancers. It has been suggested that some angiotensin receptor blockers (ARBs) could reduce the proliferation of cancer cells. The role of NF-κB pathway has

全球贸易项目编号

货号GTIN
SML1394-50MG04061837107917

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持